Related Experiment Video
Updated: May 21, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
JCL Roundtable: Prediabetes
Kevin C Maki1, Carol F Kirkpatrick2, Jaime Almandoz3
1Midwest Biomedical Research, Addison, IL, USA (Drs Maki, Kirkpatrick); Department of Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA (Dr Maki).
Insights
Prediabetes impacts over a third of US adults, increasing risks for type 2 diabetes and other serious conditions. Addressing excess adiposity through lifestyle changes and medication is crucial for management and prevention.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cardiovascular Health
Background:
- Prediabetes affects over 1 in 3 US adults, significantly raising risks for type 2 diabetes, cardiovascular disease, chronic kidney disease, and dementia.
- Excess adiposity is the primary risk factor for prediabetes, exacerbating cardiometabolic issues like dyslipidemia and insulin resistance.
Purpose of the Study:
- To discuss lifestyle and pharmacologic interventions for managing prediabetes.
- To explore strategies for preventing associated health risks in prediabetic individuals.
- To emphasize the role of addressing excess adiposity in prediabetes management.
Main Methods:
- A roundtable discussion format featuring experts in the field.
- Exploration of various intervention strategies including lifestyle modifications, pharmacotherapy, and metabolic surgery.
- Focus on patient-centered care and shared decision-making.
Main Results:
- Interventions targeting excess adiposity are vital for prediabetes management.
- A combination of lifestyle, pharmacologic, and surgical approaches can be effective.
- Shared decision-making is key for patient adherence and treatment success.
Conclusions:
- Effective management of prediabetes requires addressing excess adiposity through comprehensive strategies.
- Patient involvement in treatment planning enhances the likelihood of successful outcomes.
- Timely interventions can mitigate the severe health risks associated with prediabetes.
Abstract:
Prediabetes affects more than 1 in 3 adults in the United States and is associated with increased risks of type 2 diabetes, cardiovascular diseases, chronic kidney disease, and dementia. Excess adiposity is the strongest risk factor for prediabetes, and can contribute to several other cardiometabolic risk factors, such as dyslipidemia and insulin resistance. This Journal of Clinical Lipidology Roundtable presents a conversation between Drs Jaime P. Almandoz, Carol F. Kirkpatrick, and Kevin C. Maki, who discussed lifestyle and pharmacologic interventions for the management of prediabetes and the prevention of associated health risks. The discussion highlights the importance of interventions for addressing excess adiposity in those with prediabetes, including lifestyle, pharmacotherapy, and metabolic surgery, along with involving patients in shared decision-making conversations to identify, implement, and maintain an effective treatment plan.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:21Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
Published on: October 6, 2023
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Chronic Pancreatitis II: Collaborative Care
Assessment: